Assay Development and Screening Technology (ADST)

Published by NCATS

High Throughput ScreeningNCATSSmall Molecule

One of the first steps in the drug development process is creating test systems — called assays — on which researchers assess the effects of chemical compounds on cellular, molecular or biochemical processes of interest. At NCATS, the experts in the Assay Development and Screening Technology (ADST) program work to optimize assays requested or submitted by the biomedical research community for high-throughput small-molecule screening

View this resource Bookmark this resource

the Biomedical Data Translator

Published by NCATS

DatabaseNCATS

NCATS launched the Biomedical Data Translator (Translator) program to accelerate biomedical translation for the research community. Through this program, NCATS will integrate multiple types of existing data sources and reveal potential relationships across the spectrum of data types.

View this resource Bookmark this resource

A Specialized Platform for Innovative Research Exploration (ASPIRE)

Published by NCATS

ASPIREReproducibilitySmall Molecule

By addressing long-standing challenges in the field of chemistry, including lack of standardization, low Reproducibility and an inability to predict how new chemicals will behave, ASPIRE is designed to bring novel, safe and effective treatments to more patients more quickly at lower cost.

View this resource Bookmark this resource

Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses)

Published by NCATS

Repurposing

The New Therapeutic Uses program aims to improve the process of developing new treatments and cures for disease by finding new uses for assets that already have cleared several key steps along the development path (also known as Drug Repurposing).

View this resource Bookmark this resource